Pregnancy is often expected to be a joyful time, yet many women experience depression during pregnancy. One of the most common questions patients ask is:
“Should I continue treatment if I become pregnant?”
The answer depends on the individual, but one important fact is often overlooked: untreated depression can carry significant risks for both mother and baby.
Understanding the Risks of Untreated Depression
When discussing treatment during pregnancy, many women focus on the potential risks of medication exposure. However, depression itself can affect pregnancy outcomes.
Research has linked untreated depression during pregnancy to:
- Poor prenatal care
- Inadequate nutrition
- Sleep disruption
- Increased use of alcohol, nicotine, or other substances
- Higher rates of preterm delivery
- Low birth weight
- Difficulties with maternal-infant bonding
- Increased risk of postpartum depression
For the mother, depression can significantly impair daily functioning, relationships, work performance, and the ability to care for herself and other children. In severe cases, it may lead to hopelessness, self-harm, or suicidal thinking.
The Massachusetts General Hospital Center for Women’s Mental Health emphasizes that treatment decisions during pregnancy should consider not only the potential risks of medication exposure but also the well-established risks of untreated psychiatric illness.
Are Antidepressants Used During Pregnancy?
Yes. Antidepressants are commonly used during pregnancy when the benefits outweigh the potential risks.
The most commonly prescribed medications belong to a class called Selective Serotonin Reuptake Inhibitors (SSRIs). These medications have been extensively studied and are often considered when depression is moderate to severe, recurrent, or significantly affects daily functioning.
Not every pregnant woman with depression requires medication. Some women improve with psychotherapy, lifestyle changes, social support, and close monitoring. However, for women with a history of severe or recurrent depression, hospitalization, suicidal thoughts, or previous postpartum depression, continuing treatment may be the safer option.
Current research is reassuring that treatment decisions should be guided by the overall health of the mother and baby, taking into account both the risks of treatment and the risks of untreated illness.
Treatment Requires an Individualized Approach
There is no single right answer for every patient.
Factors that influence treatment decisions include:
- Severity of depression
- History of recurrent episodes
- Previous response to treatment
- Prior postpartum depression
- Risk of relapse if treatment is stopped
- Medical and pregnancy history
- Personal preferences and values
Most importantly, treatment decisions should be made collaboratively between the patient, her psychiatrist, and her OB/GYN. Open communication between providers helps ensure that both maternal mental health and pregnancy-related concerns are addressed, allowing for the safest and most effective treatment plan.
The Bottom Line
The question is not simply whether antidepressants are safe during pregnancy.
The more important question is:
What is the safest way to keep both mother and baby healthy?
For some women, therapy and support may be enough. For others, continuing antidepressant treatment may significantly reduce the risks associated with untreated depression.
Depression during pregnancy is a medical condition, not a personal failure. Seeking treatment is one of the most important steps a mother can take to protect her own well-being and the health of her baby.